Aluminum hydroxide and Omalizumab Subcutaneous
Determining the interaction of Aluminum hydroxide and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aluminum hydroxide
Brand name: Amphojel, Alu-Cap, Dialume, Alu-Tab, Alternagel, Aloh-Gel
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aluminum hydroxide-Ombitasvir, Paritaprevir, and Ritonavir
- Aluminum hydroxide-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Aluminum hydroxide-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Aluminum hydroxide-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Aluminum hydroxide-Omeclamox-Pak
- Aluminum hydroxide-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Aluminum Hydroxide and Magnesium Carbonate Chewable Tablets
- Omalizumab Subcutaneous-Aluminum Hydroxide and Magnesium Carbonate Suspension
- Omalizumab Subcutaneous-Aluminum Hydroxide and Magnesium Hydroxide Chewable Tablets
- Omalizumab Subcutaneous-Aluminum Hydroxide and Magnesium Hydroxide Suspension
- Omalizumab Subcutaneous-Aluminum Hydroxide and Magnesium Trisilicate
- Omalizumab Subcutaneous-Aluminum hydroxide, magnesium hydroxide, and simethicone